Join us for our second four-part webinar series on Thursday 16th September 2021
August’s paper of the month looks at the PRODIGE-7 trial, a multicentre randomised open-label, phase 3 trial which sought to determine whether hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreductive surgery for colorectal peritoneal metastases
Gabriela Möslein is ESCP's Assistant Programme Committee Chair and Director of the Center for Hereditary Tumors at BETHESDA Khs. Duisburg in Germany.
David Zimmerman is ESCP's representative on the European Union of Medical Specialists, and colorectal surgeon at Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Oded Zmora is ESCP's President Elect. He is a Professor at Shamir Medical Center, Tel Aviv, Israel.